title: Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.
abstract: A localized and regulated cascade of proteolytic events is a prerequisite for normal haemostasis. The activation of factor X by activated factor IX (factor IXa) in the presence of activated factor VIII (factor VIIIa) is essential for the formation of a fibrin clot at sites of vascular injury. We observed sustained activation of factor X on the surface of vascular endothelial cells, whereas, in agreement with others, on synthetic negatively charged phospholipid vesicles and activated blood platelets factor X activation is transient and starts to decline a few minutes after the onset of the reaction. We examined the mechanism responsible for these differences in factor X activation. Procoagulant membrane and solution were analysed separately for the occurrence of factor VIII and its activation fragments. On negatively charged phospholipid vesicles, on dissociation of factor VIIIa, the 67 kDa light-chain fragment remains associated with the lipid membrane. As a result, factor VIII-binding sites remain occupied, and dampening of factor X activation occurs. In contrast, on monolayers of endothelial cells, no residual factor VIIIa fragments associated with the cell membrane were observed. During endothelial-cell-mediated activation of factor X, accumulation of factor VIIIa fragments was observed in the solution phase only. This finding suggests that, on endothelial cells, factor VIII-binding sites remain accessible for further factor VIII binding, guaranteeing sustained activation of factor X. These data demonstrate that the nature of the procoagulant membrane contributes to the regulation of the cofactor activity of factor VIII and thereby affects the progress of factor X activation.
authors.affiliation: Department of Blood Coagulation, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, 1066 CX Amsterdam, The Netherlands.
authors.forename: H J
authors.initials: HJ
authors.lastname: Brinkman
authors.forename: P
authors.initials: P
authors.lastname: Koster
authors.forename: K
authors.initials: K
authors.lastname: Mertens
authors.forename: J A
authors.initials: JA
authors.lastname: van Mourik
mesh_terms: D001665:Binding Sites; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000378:metabolism*; D004789:Enzyme Activation; D005169:Factor VIII / Q000378:metabolism*; D015944:Factor VIIIa / Q000378:metabolism*; D005170:Factor X / Q000378:metabolism*; D006801:Humans; D008081:Liposomes / Q000378:metabolism*; D008563:Membrane Lipids / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism; D014471:Umbilical Veins
chemical_list: D008081:Liposomes; D008563:Membrane Lipids; D010743:Phospholipids; D015944:Factor VIIIa; D005169:Factor VIII; D005170:Factor X